These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9127893)

  • 1. Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development.
    Sansonetti P; Phalipon A
    Res Immunol; 1996; 147(8-9):595-602. PubMed ID: 9127893
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis and immunology in shigellosis: applications for vaccine development.
    Hale TL; Keren DF
    Curr Top Microbiol Immunol; 1992; 180():117-37. PubMed ID: 1380415
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis, genetics of virulence, and immunity in Shigellosis.
    Formal SB; Kapfer C; Hale TL
    Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():329-42. PubMed ID: 3138359
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to experimental mouse shigellosis.
    Rauss K; Kétyi I
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):491-6. PubMed ID: 5666686
    [No Abstract]   [Full Text] [Related]  

  • 8. An update on Shigella vaccines.
    Ashkenazi S; Cohen D
    Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental study of postvaccination and postinfectious immunity to dysenteria in guinea-pigs.
    Manolov DG; Kosturkov GB
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):347-52. PubMed ID: 5629951
    [No Abstract]   [Full Text] [Related]  

  • 10. Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development.
    Phalipon A; Sansonetti PJ
    Crit Rev Immunol; 2003; 23(5-6):371-401. PubMed ID: 15030306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis.
    Fernandez MI; Sansonetti PJ
    Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies on shigellosis by the mouse model technique. I. Antiinfective immunity of actively immunized mice.
    Rauss K; Kétyi I
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):377-86. PubMed ID: 5871082
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological studies on shigellosis by the mouse model technique. I. Antiinfective immunity of actively immunized mice.
    Rauss K; K0etyi I
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):377-86. PubMed ID: 5871033
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental approach in studies on pathogenesis of bacillary dysentery--with special references to the invasion of bacilli into intestinal mucosa.
    Ogawa H
    Acta Pathol Jpn; 1970 Aug; 20(3):261-77. PubMed ID: 4994630
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for development of potential candidate Shigella vaccines.
    Lindberg AA; Pál T
    Vaccine; 1993; 11(2):168-79. PubMed ID: 8438615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseases.
    Robbins JB; Chu C; Watson DC; Szu SC; Daniels EM; Lowe CU; Schneerson R
    Rev Infect Dis; 1991; 13 Suppl 4():S362-5. PubMed ID: 2047664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenic properties of live lyophilized dysentery vaccine in experiments on monkeys].
    Sergeev VV; Mikhaĭlov IF; Gleĭberman SE; Iuditskaia NM; Kavtaradze KN
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):26-32. PubMed ID: 4980669
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern views on the pathogenesis of dysentery: the role of invasion and the toxic action of Shigella].
    Pokrovskiĭ VI; Bondarenko VM; Polotskiĭ IuE; Iushchuk ND
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):101-10. PubMed ID: 2201151
    [No Abstract]   [Full Text] [Related]  

  • 19. Shigella vaccines.
    Formal SB; Hale TL; Kapfer C
    Rev Infect Dis; 1989; 11 Suppl 3():S547-51. PubMed ID: 2669098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress towards development of a Shigella vaccine.
    Camacho AI; Irache JM; Gamazo C
    Expert Rev Vaccines; 2013 Jan; 12(1):43-55. PubMed ID: 23256738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.